Agher R - Search Results

1

Factors associated with the selection of mutations conferring resistance to protease inhibitors (PIs) in PI-experienced patients displaying treatment failure on darunavir.

Lambert-Niclot S, Flandre P, Canestri A, Peytavin G, Blanc C, Agher R, Soulié C, Wirden M, Katlama C, Calvez V, Marcelin AG. Lambert-Niclot S, et al. Among authors: agher r. Antimicrob Agents Chemother. 2008 Feb;52(2):491-6. doi: 10.1128/AAC.00909-07. Epub 2007 Nov 26. Antimicrob Agents Chemother. 2008. PMID: 18039922 Free PMC article.

2

Outcome of kidney transplant recipients with previous human herpesvirus-8 infection.

Francès C, Mouquet C, Marcelin AG, Barete S, Agher R, Charron D, Benalia H, Dupin N, Piette JC, Bitker MO, Calvez V. Francès C, et al. Among authors: agher r. Transplantation. 2000 May 15;69(9):1776-9. doi: 10.1097/00007890-200005150-00008. Transplantation. 2000. PMID: 10830210

3

Impact of highly active antiretroviral therapy on onset of Mycobacterium avium complex infection and cytomegalovirus disease in patients with AIDS.

Baril L, Jouan M, Agher R, Cambau E, Caumes E, Bricaire F, Katlama C. Baril L, et al. Among authors: agher r. AIDS. 2000 Nov 10;14(16):2593-6. doi: 10.1097/00002030-200011100-00023. AIDS. 2000. PMID: 11101072

4

Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.

Delaugerre C, Rohban R, Simon A, Mouroux M, Tricot C, Agher R, Huraux JM, Katlama C, Calvez V. Delaugerre C, et al. Among authors: agher r. J Med Virol. 2001 Nov;65(3):445-8. J Med Virol. 2001. PMID: 11596076

5

[Epidemiological features and incidence trends of primary cerebral lymphomas observed in 80 HIV-infected patients from 1983 to 1999].

Rigolet A, Bossi P, Caumes E, Agher R, Zeller V, Katlama C, Bricaire F. Rigolet A, et al. Among authors: agher r. Pathol Biol (Paris). 2001 Sep;49(7):572-5. doi: 10.1016/s0369-8114(01)00206-1. Pathol Biol (Paris). 2001. PMID: 11642021 Review. French.

6

Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.

Zeller V, Truffot C, Agher R, Bossi P, Tubiana R, Caumes E, Jouan M, Bricaire F, Katlama C. Zeller V, et al. Among authors: agher r. Clin Infect Dis. 2002 Mar 1;34(5):662-7. doi: 10.1086/338816. Epub 2002 Jan 24. Clin Infect Dis. 2002. PMID: 11810599

7

Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients.

Ghosn J, Lamotte C, Ait-Mohand H, Wirden M, Agher R, Schneider L, Bricaire F, Duvivier C, Calvez V, Peytavin G, Katlama C. Ghosn J, et al. Among authors: agher r. AIDS. 2003 Jan 24;17(2):209-14. doi: 10.1097/00002030-200301240-00011. AIDS. 2003. PMID: 12545081 Clinical Trial.

8

Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.

Duvivier C, Myrto A, Marcelin AG, Ghosn J, Ait-Mohand H, Schneider L, Agher R, Bricaire F, Costagliola D, Calvez V, Peytavin G, Katlama C. Duvivier C, et al. Among authors: agher r. Antivir Ther. 2003 Dec;8(6):603-9. Antivir Ther. 2003. PMID: 14760894

9

Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level.

Wirden M, Marcelin AG, Tubiana R, Valantin MA, Ghosn J, Duvivier C, Dominguez S, Paris L, Agher R, Peytavin G, Katlama C, Calvez V. Wirden M, et al. Among authors: agher r. J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):876-8. doi: 10.1097/00126334-200407010-00016. J Acquir Immune Defic Syndr. 2004. PMID: 15213573 No abstract available.

10

Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients.

Marcelin AG, Dalban C, Peytavin G, Lamotte C, Agher R, Delaugerre C, Wirden M, Conan F, Dantin S, Katlama C, Costagliola D, Calvez V. Marcelin AG, et al. Among authors: agher r. Antimicrob Agents Chemother. 2004 Dec;48(12):4687-92. doi: 10.1128/AAC.48.12.4687-4692.2004. Antimicrob Agents Chemother. 2004. PMID: 15561845 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters